ATOSSA THERAPEUTICS, INC.

Transcripts Atossa Therapeutics, Inc.

Equities

ATOS

US04962H5063

Market Closed - Nasdaq Other stock markets 01:30:00 10/05/2024 am IST			5-day change	1st Jan Change
1.69 ^USD	+0.60%		+11.18%	+92.05%

07/05	Atossa Therapeutics, Inc. Announces Support of New Breast Cancer Screening Guidelines by U.S. Preventive Services Task Force	CI
29/04	Atossa Therapeutics, Inc. Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates and (Z)-Endoxifen	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Atossa Therapeutics, Inc., Q2 2023 Earnings Call, Aug 14, 2023	14/23/14
Transcript : Atossa Therapeutics, Inc. - Special Call	04/23/04
Transcript : Atossa Therapeutics, Inc. - Special Call	25/22/25
Transcript : Atossa Therapeutics, Inc. - Special Call	30/21/30
Transcript : Atossa Therapeutics, Inc. Presents at LD Micro 500 Virtual Investor Conference, Sep-04-2020 09:00 AM	04/20/04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW